The latest news:

• This brain cancer drug stock has been on a tear         I usually do not report on financial stuff, but this is good news for the brain tumor community.  It shows that a brain tumor treatment can be a financial success and this will encourage other companies to enter this space!
  



• Optune open house Seattle, WA         These are always very interesting and worth going for anyone dealing with a brain tumor.
  



• Dellann Elliott Mydland, President of the EndBrainCancer Initiative, to Serve on Two National Clinical Trial Committees for NRG Oncology, an NCI-Funded Research Group        

  Congratulations to my good friend Dellann!  She is the perfect person for that job which hopefully will result in better, more "patient friendly" clinical trials!
  




• Musella Foundation Copay Assistance Program is now open!         We have not received any new funding but a few grants expired and we recycle the funds, so we have enough money to only make a few grants.
  



• Aspirin affects tumor angiogenesis and sensitizes human glioblastoma endothelial cells to temozolomide, bevacizumab, and sunitinib impairing VEGF-related signaling.         Interesting study - but it is only in the test tube. We follow Aspirin in the virtual trial but nobody has recorded it - I know many people must be taking it long term for heart protection - they just aren't recording it. If you are in the virtual trial and take long term Aspirin , please go back and post an update so we can see if it helps!
  

BrainTumor Co-Payment Assistance Program Status:

• Almost closed to new applicants - Call first